Significats de hemostatic agents en anglès

Research in 2010 identified and tested chemicals that clot blood, also known as " hemostatic agents."

These observations validate the consideration of Ta-MBGs as hemostatic agents as they do not cause significant lysis of red blood cells.

Therefore, synthetic hemostatic agents that can be delivered intravenously and encourage stable clot formation after localizing to sites of vascular injury are particularly appealing.

Topical hemostatic agents are used during surgical intervention when conventional methods are not sufficient because of the site of surgery or degree of bleeding.

While there are currently many well-established topical hemostatic agents for field administration, there are still limited tools to staunch bleeding at less accessible injury sites.

We investigated whether direct injection of hemostatic agents into injury sites under the guidance of contrast-enhanced ultrasound (CEUS) can decrease blood loss from liver trauma.